← back to search

Barbara Dewaele

KU Leuven · BE
Area of research
Pulmonary and Respiratory Medicine · Gastroenterology
Research interest
Research interests include Biology, Cancer research, Medicine, Computational biology, Malignancy, and Cancer.
h-index
citations
555
works
10
NIH funding
primary concept
email

Recent publications

Integration of Optical Genome Mapping in the Cytogenomic and Molecular Work‐Up of Hematological Malignancies: Expert Recommendations From the International Consortium for Optical Genome Mapping
American Journal of Hematology 2025cited by 15position: middledoi
A framework for the clinical implementation of optical genome mapping in hematologic malignancies
American Journal of Hematology 2024cited by 47position: middledoi
Full characterization of unresolved structural variation through long-read sequencing and optical genome mapping
Scientific Reports 2024cited by 18position: middledoi
Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes
Journal of Molecular Diagnostics 2024cited by 16position: middledoi
Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping
American Journal of Hematology 2022cited by 71position: lastdoi
Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies
EClinicalMedicine 2021cited by 82position: middledoi
Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs)
Clinical Sarcoma Research 2019cited by 46position: middledoi
Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors
Annals of Oncology 2018cited by 57position: middledoi
Identification of a novel, recurrent <i>MBTD1‐CXorf67</i> fusion in low‐grade endometrial stromal sarcoma
International Journal of Cancer 2013cited by 136position: firstdoi
Ponatinib is active against imatinib-resistant mutants of FIP1L1-PDGFRA and KIT, and against FGFR1-derived fusion kinases
Leukemia 2012cited by 67position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Joris Vermeesch · KU Leuven4 papers (2018–2024)Peter Vandenberghe · Memorial Sloan Kettering Cancer Center4 papers (2012–2021)Maria Dêbiec‐Rychter · Center for Human Genetics4 papers (2012–2024)Jan Cools · KU Leuven3 papers (2012–2022)Katrina Rack · KU Leuven3 papers (2022–2025)Mar Mallo · Universitat Autònoma de Barcelona2 papers (2024–2025)Daan Dierickx · Sciensano (Belgium)2 papers (2018–2021)Huiwen Che · KU Leuven2 papers (2018–2021)Gordana Raca · University of Southern California2 papers (2024–2025) · 2 papers (2024–2025)Ravindra Kolhe · Jackson Laboratory2 papers (2024–2025)Charlotte Maggen · Europe Hospitals2 papers (2018–2021)Blanca Espinet · Hospital Universitario Puerta de Hierro Majadahonda2 papers (2024–2025)Vincent Vandecaveye · University Radiology2 papers (2018–2021)Rashmi Kanagal‐Shamanna · The University of Texas MD Anderson Cancer Center2 papers (2024–2025)Liesbeth Lenaerts · KU Leuven2 papers (2018–2021)Nathalie Brison · KU Leuven2 papers (2018–2021)Isabelle Vanden Bempt · Institute of Human Genetics2 papers (2021–2024)Françesc Solé · Universitat Autònoma de Barcelona2 papers (2024–2025)Adam C. Smith · University Health Network2 papers (2024–2025)